The $10.9 billion acquisition of Apogee (APGE.US) is completed! AbbVie (ABBV.US) accomplishes its largest merger since 2019, expected to contribute revenue starting from 2032.
AbbVie (ABBV.US) announced on Thursday that it has completed its $10.9 billion acquisition of anti-inflammatory drug developer Apogee Therapeutics (APGE.US).
According to Jinse Finance APP, AbbVie (ABBV.US) announced on Thursday that it has completed the acquisition of anti-inflammatory drug developer Apogee Therapeutics (APGE.US) in a deal valued at $10.9 billion.
This transaction is the largest bolt-on acquisition by the pharmaceutical giant since 2019. Jinse Finance APP first reported on this in June of this year.
AbbVie expects this acquisition will have a negative impact on its adjusted diluted earnings per share (EPS), with a reduction of $0.14 in 2026 (for part of the year), $0.46 in 2027, and anticipates that accretion will begin in 2032.
The company reiterated its previously issued full-year 2026 adjusted diluted EPS guidance of $13.87 to $14.07 (market consensus is $14.01). This guidance already includes the $0.14 per share dilution related to the completion of the Apogee acquisition. The EPS guidance also incorporates a $0.58 per share adverse impact resulting from acquired in-process R&D (IPR&D) and milestone expenses year to date through the end of the second quarter.
In addition, the company reaffirmed its third quarter adjusted EPS guidance, ranging from $3.84 to $3.88 per share (market consensus is $3.84).
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japan's Finance Minister says Besant has long believed the yen is undervalued
Waller votes "No" for a "6 to 5"! The key to the Federal Reserve’s September rate hike decision might actually be Powell?
Bianco Research founder Bianco stated that Waller has expressed a preference for keeping interest rates unchanged. The current voting landscape for the September Federal Reserve meeting stands at 6 votes for maintaining rates and 5 votes for a rate hike. Governor Powell's stance remains unclear and he could become the decisive voter. With less than two weeks until the meeting, the probability of a rate hike is now close to 50/50, and Powell's silence has become a source of uncertainty.
Crypto prices
More
